Hepatocellular adenoma diagnostic study of choice

	Hepatocellular adenoma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hepatocellular adenoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hepatocellular adenoma diagnostic study of choice On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hepatocellular adenoma diagnostic study of choice All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hepatocellular adenoma diagnostic study of choice
CDC on Hepatocellular adenoma diagnostic study of choice
Hepatocellular adenoma diagnostic study of choice in the news
Blogs on Hepatocellular adenoma diagnostic study of choice
Directions to Hospitals Treating Hepatocellular adenoma
Risk calculators and risk factors for Hepatocellular adenoma diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]

Overview

The diagnostic approach of hepatocellular adenoma involves the use of radiological investigation with or without surgical resection and biopsy. Surgical resection and biopsy remains the gold standard for definitive diagnosis making.

The diagnostic approach of hepatocellular adenoma involves the use of radiological investigation with or without surgical resection and biopsy.^[1]
The radiological diagnostic yield for hepatocellular adenoma is 90%.^[2]
Surgical resection and biopsy remains the gold standard for definitive diagnosis making.^[3]^[4]
Biopsy is strongly considered if the imaging results are inconclusive.^[5]

↑ Adarsh Vijay, Ahmed Elaffandi & Hatem Khalaf (2015). "Hepatocellular adenoma: An update". World journal of hepatology. 7 (25): 2603–2609. doi:10.4254/wjh.v7.i25.2603. PMID 26557953. Unknown parameter |month= ignored (help)
↑ P. Herman, V. Pugliese, M. A. Machado, A. L. Montagnini, M. Z. Salem, T. Bacchella, L. A. D'Albuquerque, W. A. Saad, M. C. Machado & H. W. Pinotti (2000). "Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment". World journal of surgery. 24 (3): 372–376. PMID 10658075. Unknown parameter |month= ignored (help)
↑ P. Herman, V. Pugliese, M. A. Machado, A. L. Montagnini, M. Z. Salem, T. Bacchella, L. A. D'Albuquerque, W. A. Saad, M. C. Machado & H. W. Pinotti (2000). "Hepatic adenoma and focal nodular hyperplasia: differential diagnosis and treatment". World journal of surgery. 24 (3): 372–376. PMID 10658075. Unknown parameter |month= ignored (help)
↑ Ludger Barthelmes & Iain S. Tait (2005). "Liver cell adenoma and liver cell adenomatosis". HPB : the official journal of the International Hepato Pancreato Biliary Association. 7 (3): 186–196. doi:10.1080/13651820510028954. PMID 18333188.
↑ Ludger Barthelmes & Iain S. Tait (2005). "Liver cell adenoma and liver cell adenomatosis". HPB : the official journal of the International Hepato Pancreato Biliary Association. 7 (3): 186–196. doi:10.1080/13651820510028954. PMID 18333188.